Nectar Lifesciences Limited has informed the Exchange about corrigendum for public Announcement - Buyback of Shares
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences Limited has filed a corrigendum (correction or revision) to its earlier public announcement regarding a buyback of its shares. The original buyback announcement had been made previously, and this filing updates or corrects details in that announcement. Specific revised details such as revised price, quantity, or timeline are not provided in this filing. Shareholders should refer to the corrigendum document on the NSE portal for the exact changes made. This is a procedural update and not a new corporate action.
A corrigendum to a buyback announcement is generally a minor procedural update and is unlikely to materially impact the stock price. Shareholders should review the revised terms to understand any changes to the buyback offer, but the underlying intent to buy back shares remains the same.